Skip to main content

Table 1 Treatment schedule weeks 1 to 80

From: Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

  

Early group

Delayed group

Morning

Noon

Evening

Morning

Noon

Evening

Phase 1

Week 1 (capsules)

50/12.5

Placebo

50/12.5

Placebo

Placebo

Placebo

Week 2 (capsules)

100/25

50/12.5

50/12.5

Placebo

Placebo

Placebo

Weeks 3 to 40 (tablets)

100/25

100/25

100/25

Placebo

Placebo

Placebo

Phase 2

Week 41 (capsules)

100/25

100/25

100/25

50/12.5

Placebo

50/12.5

Week 42 (capsules)

100/25

100/25

100/25

100/25

50/12.5

50/12.5

Week 43 to 80 (tablets)

100/25

100/25

100/25

100/25

100/25

100/25

  1. Doses are written as levodopa/carbidopa milligram